Updates in Cervical Cancer Treatment
- PMID: 31815773
- DOI: 10.1097/GRF.0000000000000507
Updates in Cervical Cancer Treatment
Abstract
Although rates of cervical cancer in the United States have been declining due to vaccination and screening efforts, it remains the fourth most common cancer in women worldwide and is still far from being eradicated, even in developed nations. This review discusses recent developments in cervical cancer treatment and reviews the literature supporting recent practice changes encompassing staging, surgical management, radiation, chemotherapy, targeted agents including immunotherapy, and imaging.
References
-
- Bhatla N, Aoki D, Sharma DN, et al. FIGO Cancer Report 2018: cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143(suppl 2):22–36.
-
- Matuso K, Machida H, Mandelbaum RS, et al. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019;152:87–93.
-
- Berek JS, Matuso K, Grubbs BH, et al. Multidisciplinary perspectives on newly revise 2018 FIGO staging of cancer of the cerxi uteri. J Gynecol Oncol. 2019;30:e40.
-
- Lanciano R, Calkins A, Bundy BN, et al. Randomized comparision of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervical cancer: a gynecologic oncology group study. J Clin Oncol. 2005;23:8289–8295.
-
- Havrilesky LJ, Kulasingam SL, Matchar DB, et al. FDG-PET for management of cercial and ovarian cancer. Gynecol Oncol. 2005;97:183–191.
